ABBOTT LABORATORIES Net Income 2007-2025 | ABT
Beta
What is net income?
Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.
What is ABBOTT LABORATORIES's current net income?
ABBOTT LABORATORIES (ABT) annual net income for 2024 was $13.40B, a 134.18% increase from 2023. ABBOTT LABORATORIES net income for the quarter ending September 30, 2025 was $1.64B.
What was ABBOTT LABORATORIES's net income in 2023?
ABBOTT LABORATORIES annual net income for 2023 was $5.72B, a 17.45% decline from 2022.
What was ABBOTT LABORATORIES's net income in 2022?
ABBOTT LABORATORIES annual net income for 2022 was $6.93B, a 1.95% decline from 2021.
What is ABBOTT LABORATORIES's 5-year net income CAGR?
ABBOTT LABORATORIES net income grew at a compound annual growth rate (CAGR) of 29.45% from FY2019 to FY2024, going from $3.69B to $13.40B over 5 years.
Net Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+29.4%
FY2019
$3.69B
→
FY2024
$13.40B
070809101112131415161718192021222324
5 years selected
Net Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $13.40B | +134.2% | 10-K |
| FY2023 | $5.72B | -17.5% | 10-K |
| FY2022 | $6.93B | -2.0% | 10-K |
| FY2021 | $7.07B | +57.3% | 10-K |
| FY2020 | $4.50B | +21.9% | 10-K |
| FY2019 | $3.69B | +55.7% | 10-K |
| FY2018 | $2.37B | +396.4% | 10-K |
| FY2017 | $477.0M | -65.9% | 10-K |
| FY2016 | $1.40B | -68.3% | 10-K |
| FY2015 | $4.42B | +93.7% | 10-K |
| FY2014 | $2.28B | -11.3% | 10-K |
| FY2013 | $2.58B | -56.8% | 10-K |
| FY2012 | $5.96B | +26.1% | 10-K |
| FY2011 | $4.73B | +2.2% | 10-K |
| FY2010 | $4.63B | -19.5% | 10-K |
| FY2009 | $5.75B | +17.7% | 10-K |
| FY2008 | $4.88B | +35.3% | 10-K |
| FY2007 | $3.61B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →